A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc.
Boston Scientific Corporation
Cancer Research UK
Boston Scientific Corporation
Pfizer
Eli Lilly and Company
Inhibrx Biosciences, Inc
Cancer Research UK
Elevation Oncology
Eli Lilly and Company
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Thomas Jefferson University
Thomas Jefferson University
Revolution Medicines, Inc.
Stanford University
Boston Scientific Corporation
Revolution Medicines, Inc.
Imunon
OncoSil Medical Limited
Kyowa Kirin Co., Ltd.
Taipei Veterans General Hospital, Taiwan
University Hospital, Antwerp
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
The Second Affiliated Hospital of Fujian Medical University
Hoffmann-La Roche
Celgene
Revolution Medicines, Inc.
Sociedad Española de Medicina Nuclear e Imagen Molecular
Jiangxi Provincial Cancer Hospital
Revolution Medicines, Inc.
Zhejiang University
State Scientific Centre of Coloproctology, Russian Federation
Seoul National University Bundang Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Gachon University Gil Medical Center
Zhejiang University
Isofol Medical AB
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Royal Marsden NHS Foundation Trust
Royal Marsden NHS Foundation Trust
Royal Marsden NHS Foundation Trust
Exact Sciences Corporation
Yale University
Metabiomics Corp
Novartis